Remove 2013 Remove Competition Remove Patients Remove Prescription
article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. Conclusion.

article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

Because nearly all prescriptions are now written electronically. When a patient meets predetermined triggering criteria, a brand message appears in the EHR. The Point of Care Marketing Association (POCMA) is the Go-to Source for POC Education/Advocacy Founded in 2013, POCMA supports the POC channel through education and advocacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. RxPass offers more than 50 select prescriptions at no additional cost for $5 per month.

Retail 52
article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.